VAIM partners with Cartessa Aesthetics to Bring Korea's Leading Biostimulator Brand, JUVELOOK, to the U.S. Marketplace
Korea's #1 biostimulator brand, JUVELOOK, provides the professional skincare market with innovative PDLLA and hyaluronic acid technology to complement aesthetic procedures.
MELVILLE, N.Y., Nov. 10, 2026 /PRNewswire/ -- Cartessa Aesthetics, a premier North American aesthetic medical device company, has partnered with VAIM, a South Korean biomaterials innovator and the company behind the globally recognized JUVELOOK brand, to introduce JUVELOOK Skincare Serum to the United States market. JUVELOOK Skincare Serum is the topical post-procedure skincare product combining Poly-D,L-Lactic Acid (PDLLA) and Hyaluronic Acid (HA). Cartessa Aesthetics will be the exclusive distributor of JUVELOOK Skincare Serum offering aesthetic providers a complement to office-based procedures like RF microneedling and laser resurfacing and a way to elevate the post-procedure patient experience.
Recognized as Korea's No. 1 biostimulator brand, JUVELOOK has established a significant international presence, with more than 3 million vials sold globally and distribution across more than 60 countries. Its expansion into the U.S. professional skincare market represents a new chapter for the brand, introducing its established PDLLA and HA technology in a topical formulation designed specifically for aesthetic practices.
JUVELOOK Skincare Serum combines PDLLA, a biocompatible, biodegradable polymer recognized for its collagen-stimulating properties in aesthetic medicine, with HA in a proprietary hybrid formulation. JUVELOOK's patented PDLLA technology features uniquely engineered spherical particles with a porous internal network structure designed to promote gradual, controlled bioregeneration and biodegradation.
"The JUVELOOK brand has earned the trust of aesthetic providers around the world through our commitment to innovation and advanced biomaterial technology," said Jonghyun Park, CEO of VAIM. "Expanding into the United States with Cartessa Aesthetics represents an important milestone for our company. Cartessa's established relationships with leading aesthetic practices and its deep understanding of the U.S. market make them an ideal partner."
The introduction of JUVELOOK Skincare Serum further expands Cartessa's portfolio beyond energy-based devices, reinforcing its commitment to providing aesthetic practices with innovative solutions that support both clinical outcomes and business growth. "While our core competency is to identify and commercialize the globes' leading aesthetic devices for North American providers, we know patient experience doesn't start and end with the device," shared Chief Marketing Officer and Head of Commercialization, Jill Later. "Our mission is to support our customers in finding the best aesthetic solutions for their patients and their practices. Therefore, we are thrilled to bring an innovative product like JUVELOOK Skincare Serum to our network of aesthetic providers and accelerate its adoption with VAIM, a pioneer in Korean skincare.
JUVELOOK Skincare Serum is now available to qualified aesthetic practices in the United States exclusively through Cartessa Aesthetics. For more information or to place an order, contact a Cartessa representative or visit www.cartessaaesthetics.com/juvelook
ABOUT CARTESSA AESTHETICS: Cartessa Aesthetics is a leading North American aesthetic company focused on cutting-edge technology and industry-leading customer support. Thanks to an independent business model and established relationships with top global manufacturers, Cartessa's product portfolio offers true competitive advantages for practices and patients across every aesthetics category. Customers benefit from expertly vetted devices and end-to-end support to maximize clinical outcomes and return on investment.
ABOUT VAIM: Founded in 2014, VAIM is a global medical aesthetics company specializing in regenerative solutions based on its proprietary, patented PDLLA technology. In 2019, VAIM launched JUVELOOK, a collagen biostimulator designed to stimulate extracellular matrix (ECM) production, including collagen and elastin, to improve skin elasticity and the appearance of wrinkles. JUVELOOK gained rapid recognition among aesthetic medical professionals for its safety and efficacy and was awarded "Best Injectable for Skin Revitalization" at the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco in March 2025. Today, VAIM exports its products to more than 60 countries worldwide.
